Singapore markets close in 4 hours 2 minutes

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0100-0.0400 (-3.81%)
At close: 04:00PM EDT
1.0400 +0.03 (+2.97%)
After hours: 04:08PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts9999
Avg. Estimate-0.2-0.18-0.8-0.63
Low estimate-0.34-0.31-1.21-1.35
High estimate-0.12-0.1-0.53-0.4
Year ago EPS-0.42-0.41-1.27-0.8
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts9888
Avg. Estimate1.82M1.83M7.89M7.74M
Low estimate660k660k4.37M2.63M
High estimate2.5M2.6M10.19M12.19M
Year ago sales1.9MN/A31.25M7.89M
Sales growth (year/est)-4.20%N/A-74.80%-1.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.45-0.48-0.34-0.29
Actual EPS-0.42-0.41-0.02-0.24
Difference0.030.070.320.05
Surprise %6.70%14.60%94.10%17.20%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.2-0.18-0.8-0.63
7 days ago-0.2-0.18-0.8-0.63
30 days ago-0.25-0.23-0.99-0.82
60 days ago-0.25-0.23-0.99-0.82
90 days ago-0.25-0.22-1.12-1.16
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days7686
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACRSIndustrySector(s)S&P 500
Current qtr.52.40%N/AN/AN/A
Next qtr.56.10%N/AN/AN/A
Current year37.00%N/AN/AN/A
Next year21.30%N/AN/AN/A
Next 5 years (per annum)74.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A